Halil ÖNDER
(Yozgat Şehir Hastanesi, Nöroloji Kliniği, Yozgat)
Yıl: 2021Cilt: 27Sayı: 1ISSN: 1300-7157Sayfa Aralığı: 71 - 72Türkçe

81 0
Letter to the editor for the article ‘Super-refractoryCondition Epilepticus: A Rare Case Associated withNeuropsychiatric Systemic Lupus Erythematosus
Dergititle.paper.letter_to_editorErişime Açık
  • 1. Göl MF, Yetkin MF, Köse EG, Erdoğan FF. Nöropsikiyatrik Sistemik Lupus Eritematozus İle İlişkili Süper Refrakter Status Epileptikus: Nadir Görülen Bir Olgu. Epilepsi 2019;25(1):35–9.
  • 2. Holmqvist M, Simard JF, Asplund K, Arkema EV. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open 2015;1(1):e000168.
  • 3. Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Care Res (Hoboken) 2018;70(10):1478–87.
  • 4. Vieira-Karuta SC, Silva IC, Liberalesso PB, Bandeira M, Janz L Jr, Löhr A Jr. Epileptic seizures and EEG features in juvenile systemic lupus erythematosus. Arq Neuropsiquiatr 2008;66(3A):468– 70.
  • 5. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46(4):1029–35.
  • 6. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41(Suppl 2):S23–30.
  • 7. Guraieb-Chahín P, Cantú-Brito C, Soto-Mota A, Guerrero-Torres L, Flores-Silva F, Chiquete E, et al. Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome. Lupus 2020;29(5):437–45.
  • 8. van Zaane B, Nur E, Squizzato A, Gerdes VE, Buller HR, Dekkers OM, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 2010;8(11):2483–93.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.